Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/22/2007CA2651865A1 Cold menthol receptor-1 antagonists
11/22/2007CA2651862A1 5 ht receptor mediated neurogenesis
11/22/2007CA2651839A1 Compositions and methods for inhibiting expression of the pcsk9 gene
11/22/2007CA2651836A1 Selective inhibitors of rock protein kinase and uses thereof
11/22/2007CA2651822A1 Acetylenic heteroaryl compounds
11/22/2007CA2651817A1 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
11/22/2007CA2651813A1 Neurogenesis by modulating angiotensin
11/22/2007CA2651811A1 Method for increasing the bioavailability of benzhydryl piperazine containing compounds
11/22/2007CA2651805A1 Therapy
11/22/2007CA2651798A1 Zero-order modified release solid dosage forms
11/22/2007CA2651795A1 Composition for the treatment of resistant cancers comprising oridonin
11/22/2007CA2651765A1 A medicament containing a thiazole derivative as an active ingredient
11/22/2007CA2651758A1 Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure
11/22/2007CA2651726A1 Use of combination preparations, comprising antimycotics
11/22/2007CA2651660A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
11/22/2007CA2651658A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2651657A1 4,5-diphenyl-pyrimidinylamino substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2651654A1 Substituted azaspiro derivatives
11/22/2007CA2651646A1 Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent
11/22/2007CA2651639A1 Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007CA2651623A1 Compositions and methods for modulating the immune system
11/22/2007CA2651466A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
11/22/2007CA2651354A1 Use of 4,17.beta.-dihydroxyandrost-4-ene-3-one for treating cancers
11/22/2007CA2651283A1 Pulmonary delivery of 1.alpha.,25-dihydroxyvitamin d3 and co-administration of parathyroid hormone or calcitonin
11/22/2007CA2651136A1 Substituted thieno-fused pyrimidines as p13k inhibitors
11/22/2007CA2651067A1 Combination therapy product and uses thereof
11/22/2007CA2651064A1 Novel agents and use thereof
11/22/2007CA2651039A1 Hyaluronic acid binary mixtures and therapeutic use thereof
11/22/2007CA2650839A1 Antimicrobial therapy for bacterial infections
11/22/2007CA2650798A1 Inhibitors of human immunodeficiency virus replication
11/22/2007CA2650695A1 Methods for treating or preventing disorders using ecdysteroid compositions
11/22/2007CA2650519A1 Maleate co-crystal of azd1152
11/22/2007CA2650515A1 Benzylamine derivatives as cetp inhibitors
11/22/2007CA2650232A1 Pharmaceutical combinations
11/22/2007CA2649961A1 Polymorph forms of (2s) - (4e) -n-methyl-5- (3-isopropoxypyridin) yl] -4-penten-2-amine for the treatment of central nervous system disorders
11/22/2007CA2649489A1 Pharmaceutically acceptable salts and polymorphic forms
11/22/2007CA2649124A1 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
11/22/2007CA2649102A1 Compounds and compositions as protein kinase inhibitors
11/22/2007CA2647238A1 2,4-diamino pyrimidines as cell cycle kinase inhibitors
11/22/2007CA2635767A1 Multilayer tablet
11/22/2007CA2628031A1 Once-daily administration of central nervous system drugs
11/21/2007EP1857548A1 Means and method for inducing exon-skipping
11/21/2007EP1857547A2 Further novel forms of interfering RNA molecules
11/21/2007EP1857489A1 Microparticle and pharmaceutical composition
11/21/2007EP1857460A2 New metal complexes, method of preparing them and therapeutic uses for them
11/21/2007EP1857459A2 Pyrazolopyrimidine compound and a process for preparing the same
11/21/2007EP1857457A2 Benzimidazole derivative and its use as AII receptor antagonist
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857453A1 Fluoroalkylpyrrolidine derivative
11/21/2007EP1857450A1 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
11/21/2007EP1857447A1 Ppar-activating compound
11/21/2007EP1857446A1 Novel hsp90 inhibitor
11/21/2007EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
11/21/2007EP1857444A1 Tetrahydroisoquinoline compound and medicinal use thereof
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857442A2 Novel antimycobacterial compounds
11/21/2007EP1857440A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
11/21/2007EP1857435A2 A process for the preparation of aryloxypropylamines
11/21/2007EP1857120A1 Injection for mastitis
11/21/2007EP1857118A1 Medicinal composition for treating diabetes
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1857112A1 Anticancer composition for oral use comprising liposome containing phytosterols and prevention or treatment for cancer using the liposome
11/21/2007EP1857111A2 Composition comprising a combination of an aromatase inhibitor, a progestin and an estrogen, and its use for the treatment of endometriosis
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1857109A2 Inhibitors of melanocyte tyrosinase as tropical skin lighteners
11/21/2007EP1857108A1 Preventive or therapeutic agent for herpesvirus-related disease
11/21/2007EP1857107A1 Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion
11/21/2007EP1857106A1 Combinations of erdosteine and beta-2 agonists for treating COPD
11/21/2007EP1857105A2 Cathartic composition
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1857103A1 Transdermally absorbable preparation
11/21/2007EP1857102A1 Folic acid supplement
11/21/2007EP1857101A2 Medicaments
11/21/2007EP1856532A2 Methods and compositions for the treatment of lipid-associated disorders
11/21/2007EP1856527A2 Regulators of protein misfolding and aggregation and methods of using the same
11/21/2007EP1856521A2 Modulation of th2 lineage commitment by t-bet
11/21/2007EP1856259A1 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
11/21/2007EP1856135A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
11/21/2007EP1856131A1 Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
11/21/2007EP1856130A1 Cci-779 polymorph and use thereof
11/21/2007EP1856129A1 39-desmethoxy derivatives of rapamycin
11/21/2007EP1856128A2 Mitotic kinesin inhibitors
11/21/2007EP1856126A2 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
11/21/2007EP1856125A1 Protease inhibitor precursor synthesis
11/21/2007EP1856123A2 Small molecule inhibitors of mdm2 and uses thereof
11/21/2007EP1856117A1 Indolopyridines, benzofuranopyridines and benzothienopyridines
11/21/2007EP1856116A1 Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and raf kinase modulators
11/21/2007EP1856114A1 Benzisoxazole derivatives
11/21/2007EP1856112A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1856110A1 Oxyindole derivatives as 5ht4 receptor agonists
11/21/2007EP1856108A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions
11/21/2007EP1856107A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists
11/21/2007EP1856105A1 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor
11/21/2007EP1856104A1 Processes and compounds for the preparation of substituted naphthylindole derivatives
11/21/2007EP1856103A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
11/21/2007EP1856102A1 Medicaments for alzheimer
11/21/2007EP1856100A2 Cgrp receptor antagonists
11/21/2007EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators
1 ... 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 3509 3510 3511 3512 3513 ... 7860